Bitchute odysee Telegram Feed

Synthetic Menopausal Hormone Therapy Continues to Increase Breast Cancer and Death Rates

The headline on medscape.com (12.20.19) states, “Remarkable New Data on Menopausal Hormone Therapy.” Folks, there is NOTHING remarkable or (much) new about the data reported. What is remarkable is that the FDA, who should be working for us, has not pulled synthetic progesterone from the market even though over three decades of data have proven that it significantly increases breast cancer risk. One reason women have to suffer with the increased breast cancer risk is because the FDA was not doing its job and removing synthetic progesterone from the marketplace. Another reason is on physicians’ shoulders for prescribing this toxic therapy in the first place. If they studied endocrinology and looked at how MPA works in the body, it is not hard to predict there will be problems with it. The 2019 findings found that after 19 years of follow-up, women who used MPA had a 29% significant increased risk in breast cancer.   The original 2002 study found a 26% increase risk in breast cancer with MPA use. In terms of death from breast cancer, the 2019 report found a 45% increase in deaths from breast cancer in women who used MPA. Breast cancer affects one in seven women across the US. It is a pathetic statistic. It is also pathetic to prescribe a therapy that significantly increases a woman’s risk of developing breast cancer when there are safer versions available.

Read More

Why Are U.S. Breast Cancer Rates Out of Control?

In the US, breast cancer rates are out of control. Presently, one in seven US women suffer from breast cancer. In 2019, an estimated 268,600 women will be diagnosed with invasive breast cancer. Think about those numbers: One in seven and nearly 270,000 women diagnosed with invasive cancer—THIS YEAR!   Those numbers are unacceptable, or at least they should be! What are the Powers-That-Be doing to stem this tide? The answer: They are too busy diagnosing and treating and are not properly searching for the underlying cause of why too many US women suffer with breast cancer. We are exposed to too many synthetic hormones which can disrupt the normal hormonal milieu. Women are prescribed synthetic hormones in birth control pills and conventional hormonal replacement therapy which have been conclusively shown to increase the risk for breast cancer. Iodine deficiency is one of the main reasons we are seeing so much breast cancer. I have been writing and lecturing about iodine for almost 20 years. Iodine levels in the US have fallen over 50% during the last 40 years while at the same time breast cancer rates have risen to epidemic levels.

Read More

Thermography vs. Mammography for Early Breast Cancer Detection: Who Benefits Most?

There is a turf war between those who favor thermography and those who favor mammography for early breast cancer detection. The mammogram party is supported by federal health agencies and non-governmental organizations (NGOs) as well as the mammogram industry. For the most part, the under-supported thermography advocates are outgunned and outnumbered by the mammogram crowd, which has declared a soft, at least for now, war on thermography to restrict or deny its independent breast cancer screening use. Breast cancer cells take around five to eight years to develop enough for mammogram tumor detection. Just in time for costly, profitable treatments. But because of thermography's extreme sensitivity to infrared emissions from slight temperature variations, its images render the earliest signs of breast cancer and/or a pre-cancerous state of the breast.

Read More

Study: Vitamin D Can Lower Breast Cancer Risk 80 Percent

A study published June 15, 2018, goes beyond anecdotal experiences or theories that indicate vitamin D offers immune boosting protection against minor diseases such as colds, flues, and other respiratory diseases. It also offers protection against cancer. There have been other studies demonstrating vitamin D’s ability to protect against different cancers in the past. This latest study focused on breast cancer, which afflicts women more than any other cancer. The bulk of its focus centered on what serum levels of vitamin D did the most to prevent breast cancer.

Read More

Study: Chemo Not Necessary for 70% of Breast Cancer Victims

The results of a 10,000 plus breast cancer patient prospective (follow-up) study demonstrated that many women can refuse chemotherapy without lowering their survival risk. Dr. Robert Rowen commented on the study via his Facebook page: "This will be significant for some 70,000 American women who otherwise would be placed in a locked train to chemotherapy land. I can't tell you how many women I've seen who were told, immediately after the positive biopsy, that they must get chemotherapy. And they truly suffered." This study was published in the New England Journal of Medicine the same day it was announced at an American Society of Clinical Oncology in Chicago, June 18, 2018, where Dr. Kathy Albain announced: "With results of this groundbreaking study, we now can safely avoid chemotherapy in about 70 percent of patients who are diagnosed with the most common form of breast cancer. For countless women and their doctors, the days of uncertainty are over."

Read More

Truth About Cancer Live Event Starts During October Pink Propaganda Scam

October has been dubbed Breast Cancer Awareness month. The American Cancer Society (ACS) and the Susan G. Komen for the Cure are the two most visible fund raising groups for the multi-billion dollar cancer industry. The American Cancer Society teamed with the pharmaceutical company AstraZeneca in 1985 to create October as the breast cancer awareness month. AstraZeneca is a major chemotherapy drug manufacturer. The pink ribbon and pinking commercial products gimmick comes from the Komen clan. A small percentage of sales with those “pinked” products goes to contributing toward cancer drug research. Komen's major fund raising efforts include running for the cure, walking for the cure, and other fund raising activities where participants pay for their involvement. The multi-billion dollar cancer industry has been growing for many years now, and it depends on more clients, and NOT finding a cure so new drugs can enter the market. As an alternative to the lucrative cancer drug industry, Ty and Charlene Bollinger's Truth About Cancer events have educated hundreds of thousands of people on real cancer cures, with free online articles and health summits with the world's leading authorities on true cancer research. Mainstream media will not publish this kind of life-saving information, as they are heavily funded by the pharmaceutical and cancer industry. For the first time ever, most of these leaders in the alternative health field are gathering in Dallas, Texas this weekend (Oct. 14-16) for a live-streamed symposium that is offered free to the public.

Read More

Breast Cancer Awareness Month: Covering Up The Causes of Breast Cancer Since 1985

Did you know that AstraZeneca, manufacturer of two blockbuster breast cancer drugs (one of which is classified as a known human carcinogen), is behind Breast Cancer Awareness Month? Why is it, do you think, that during Breast Cancer Awareness Month (BCAM) you never hear the word "carcinogen" mentioned, but are barraged a million times over by the word "cure"? Truth be told, BCAM should be renamed Breast Cancer Un-Awareness Month, as it has nothing to do with generating awareness about the true causes and solutions for the breast cancer epidemic and everything to do with making the public focus on a presumably not-yet-existent "cure" to be produced through the pharmaceutical pipeline somewhere off in the future only after enough money is raised.

Read More

Mammography: Another Failed Screening Test

As reported in a September, 2015 study in JAMA Internal Medicine article, researchers studied 16,120,349 women over the age of 40 who resided in 547 counties across the U.S. during a one-year period. The researchers correlated their findings with breast cancer incidence and mortality data during the ensuing 10 years. There was no significant change in mortality in those screened with mammography. The authors noted, “Although it has been hoped that screening would allow breast-conserving surgical procedures to replace more extensive mastectomies, we saw no evidence supporting this change.” Clearly we need a better path. What should be happening is that the Powers-That-Be, such as the American Cancer Society and the Komen Foundation, should be promoting research that would identify why one in seven U.S. women have breast cancer instead of promoting a screening test—mammography–that has never been proven to decrease the mortality rate from breast cancer.

Read More

Study: Virgin Coconut Oil Reduces Symptoms of Chemo – Improves Quality of Life for Breast Cancer Patients

Once again, research into the health benefits of coconut oil is mainly being done outside of the U.S., primarily in coconut-producing countries. Here in the U.S., only pharmaceutical drugs can make health claims, by law. The FDA regulates all health claims, and only allows pharmaceutical companies that have gone through the lengthy and costly drug approval process to make such claims. No company in the U.S. would spend that kind of money on research for a product found in nature that cannot be patented. A study just published in the journal Lipids in Health and Disease looked at Malaysian women suffering from breast cancer. The study discovered that stage 3 and 4 breast cancer women who supplemented their diet with virgin coconut oil during breast cancer treatment improved fatigue, dyspnea, sleep difficulties, and loss of appetite compared to the control group. Virgin coconut oil consumption during chemotherapy also helped improve the functional status and global Quality Of Life of these breast cancer patients. In addition, it reduced the symptoms related to side effects of chemotherapy.

Read More

Taking Thyroid Hormone Increases Breast Cancer Risk By 200%

A study found that women who take thyroid hormone for at least 15 years have 200% increase in the risk of breast cancer as compared to women who did not take thyroid hormone. You read that correctly: a 200% increase risk of breast cancer in women who took thyroid hormone as compared to women who did not take thyroid hormone. How could that be? The answer is simple: The increased breast risk in thyroid supplemented women is due to iodine deficiency.

Read More

Screening Mammography Fails 99% of Women

We have been conditioned to believe that screening mammograms save lives. But do mammograms save lives? Does every woman need to have a yearly screening mammogram starting at age 40 or 50? A recent study can shed some light on whether it is wise to get screened with annual mammography.

Read More

Boycott of Komen Foundation and American Cancer Society: They Don’t Want Cures, Just Your Money

Does wearing constrictive bras for long periods of time daily contribute to breast cancer? It does, according to at least 5 research studies and numerous healthcare providers, including oncologists and MD’s. Even some lingerie manufacturers have developed new bra designs hoping to minimize lymphatic constriction and thereby help prevent breast cancer, citing the bra-cancer link for their patents. But bras are not related to cancer according to the American Cancer Society and the Susan G. Komen Foundation, fund raising giants of the cancer detection and treatment world. They consider the link absurd and unworthy of serious consideration, and unquestionably assume that research showing a link must have some other explanation besides bras. Could shrugging off the bra-cancer link be killing hundreds of thousands of women and wasting billions of dollars in unnecessary detection and treatment?

Read More

Swiss Medical Board Against Systematic Mammograms

The Swiss Medical Board has recommended that no new systematic mammography screening programs be introduced, and a time limit should be placed on existing programs. Their review of mammography screening found the recommendations are based on outdated studies and the benefits do not outweigh the risks to women. One of the largest and longest studies of mammography to date found that mammograms have absolutely no positive impact on breast cancer mortality while 22 percent of women screened will be exposed to false positives and unnecessary treatment.

Read More

Popular Antidepressant May Promote Breast Cancer

A popular antidepressant may promote breast cancer and even worse, it’s frequently prescribed to the most at-risk group: women in their 40s and 50s. We’ve told you before about the dangers of SSRIs, an incredibly popular class of antidepressants that can cause violent outbursts—both homicidal and suicidal. But now, researchers have found another alarming side effect: they may promote breast cancer. About 70% of breast cancers are sensitive to estrogen—that is, estrogen contributes to their growth. Recently, researchers have found that paroxetine—the active ingredient in Paxil and Pexeva, some of the most widely prescribed SSRI antidepressants—has an estrogenic effect that likely promotes the development and growth of breast tumors in women.

Read More

The Breast Cancer Industry Is Deceiving Women

Are regular mammograms doing more harm than good? For the past two decades, controversy has swirled around the question of the benefits of mammography. Unfortunately, breast cancer is a huge and thriving industry, and its powerhouses have lined up squarely in support of mammography. If every woman who is recommended to get a breast exam did so, it puts $8 billion dollars a year into the pockets of the radiology industry. But what does the science say? This past February, a twenty-five-year-long Canadian trial found no difference in death rates from breast cancer among women who had regular mammograms and those who did not. The Mammogram Myth may be beginning to crumble, but don’t wait for the dust to settle— research safer ways to prevent, detect, and treat breast cancer.

Read More

Arbitrary Definition of Osteoporosis: Aging Transformed Into a Disease

The present-day definitions of Osteopenia and Osteoporosis were arbitrarily conceived by the World Health Organization (WHO) in the early 90's and then projected upon millions of women's bodies seemingly in order to convince them they had a drug-treatable, though symptomless, disease. The WHO's technical definition, now used widely around the world as the gold standard, is disturbingly inept, and as we shall see, likely conceals an agenda that has nothing to do with the promotion of health.

Read More

Study: Cholesterol-Lowering Statin Drugs More than Double Breast Cancer Risk

A study found that current users of statins for ten years or longer had an 83% increased risk of invasive ductal carcinoma and a 97% increased risk of invasive lobular carcinoma, when compared to never-users of statins. Among women diagnosed with hypercholesterolemia, current users of statins for ten years or longer had a 104% increased risk of invasive ductal carcinoma and a 143% increased risk of invasive lobular carcinoma. Even more appalling is the fact that statins have never been shown, in women and most men, to prevent heart attacks and strokes. Nor have statins been shown to significantly prolong a woman or a man’s life. Perhaps women just need to say “No” to a statin prescription.

Read More

Mammograms: Where’s the Wisdom in Using a Cancer Screen That Causes Cancer?

One of the largest and longest studies of mammography to date, involving 90,000 women followed for 25 years, found that mammograms have absolutely NO impact on breast cancer mortality. Several studies over the past few years have concluded that mammograms do not save lives, and may actually harm more women than they help, courtesy of false positives, overtreatment, and radiation-induced cancers. Besides the harm caused by overtreatment, the wisdom of radiating your breasts year after year, for decades, is questionable at best, considering the fact that ionizing radiation can cause cancer. Beware of the “new and improved” type of mammogram called 3D tomosynthesis, as it exposes you to even HIGHER doses of radiation than a standard mammogram.

Read More

FAIL: Another Mammography Study Finds They Don’t Save Lives

There are already more than enough reasons for 'pink' to make you see red, not the least of which is the notion that exposing the healthy breasts of asymptomatic women to breast-cancer causing x-ray radiation for 'early detection' is the best form of 'prevention.' But now, adding to the growing awareness that mammograms don't make sense, a groundbreaking new study published in the British Medical Journal reveals regular mammogram screenings do not reduce breast cancer death rates – the only true measure of whether they benefit women who undergo them. Moreover, the study found that women in the mammography arm were more likely to be 'overdiagnosed' (a euphemism for misdiagnosed) with breast cancer that wasn't there.

Read More

Study Finds Women Still Suffering 3 Years After Breast Cancer False-Positive

Millions of women undergo them annually, but few are even remotely aware of just how many dangers they are exposing themselves to in the name of prevention, not the least of which are misdiagnosis, overdiagnosis and the promotion of breast cancer itself.

Read More